SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-042554
Filing Date
2020-12-14
Accepted
2020-12-14 16:55:57
Documents
3
Period of Report
2020-12-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea131605-8k_enzobiochem.htm 8-K 28788
2 PRESS RELEASE OF ENZO BIOCHEM, INC., DATED DECEMBER 9, 2020 ea131605ex99-1_enzobio.htm EX-99.1 81408
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3609
  Complete submission text file 0001213900-20-042554.txt   116466
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 201386858
SIC: 8071 Services-Medical Laboratories